Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

AN INVITRO LINE OF THE B-CELL TUMOR BCL1 CAN BE ACTIVATED BY LPS TO SECRETE IGM JOURNAL OF IMMUNOLOGY GRONOWICZ, E. S., DOSS, C. A., Howard, F. D., Morrison, D. C., Strober, S. 1980; 125 (3): 976-980

Abstract

An in vitro line of the B cell tumor BCL1 was developed. The cell line carried u-, S-, and A-chains on the cell surface as judged by analysis of surface iodinated proteins but did not secret Ig. ASfter stimulation with LPS, limpid A, or bacterial lipoprotein, 20 to 40% of the tumor cells matured to IgM secretors when detected in a plaque assay. Two other polyclonal B cell activators, namely dextransulphate and PPD, had at most a marginal stimulatory effect. The ability of the cells to become activated to IgM secretion as well as the expression of cell surface IgM and IgD makes the BCL1 unique among murine B cell tumors.

View details for Web of Science ID A1980KE22000003

View details for PubMedID 6157730